Work

High Expression of the Very Late Antigen (VLA)-4 (CD49d) Integrin Predicts for Reduced Risk of Relapse and Better Outcome in Pediatric Acute Myeloid Leukemia (AML): A Report From the Children's Oncology Group.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.1592.1592

Authors: Walter B. Walter, Todd A. Alonzo, Robert B. Gerbing, Franklin O. Smith, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Janet L. Franklin, Craig A. Hurwitz, Michael R. Loken, Soheil Meshinchi

Institutions: Fred Hutch Cancer Center, University of Southern California, Children's Oncology Group, Cincinnati Children's Hospital Medical Center, St. Jude Children's Research Hospital, University of Minnesota, Children's Mercy Hospital, Amgen (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592067779

FWCI:

Cites:

Cited by:

Related to: 10